intoplicine has been researched along with Periphlebitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beijnen, JH; Rodenhuis, S; Rosing, H; ten Bokkel Huinink, WW; van Gijn, R; van Tellingen, O; van Warmerdam, LJ; Vermorken, JB | 1 |
1 trial(s) available for intoplicine and Periphlebitis
Article | Year |
---|---|
Topoisomerase I/II inhibitor intoplicine administered as a 24 h infusion: phase I and pharmacologic study.
Topics: Adult; Aged; Anemia; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Half-Life; Hepatic Encephalopathy; Humans; Indoles; Infusions, Intravenous; Liver; Male; Middle Aged; Neoplasms; Phlebitis; Pyridines; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Transaminases; Treatment Outcome | 1999 |